Quercetin nanocrystals prepared using a microfluidic chip with improved in vitro dissolution

References

• Ali HSM, York P, Ali AMA, Blagden N. 2011. Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling. J Control Release. 149(2):175–181. doi: 10.1016/j.jconrel.2010.10.007.
   PubMed Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. 2005. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci. 24(1):67–75. doi: 10.1016/j.ejps.2004.09.011.
   PubMed Web of Science ®Google Scholar
• Chen H, Khemtong C, Yang X, Chang X, Gao J. 2011. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today. 16(7–8):354–360. doi: 10.1016/j.drudis.2010.02.009.
   PubMed Web of Science ®Google Scholar
• Chen M, Li W, Zhang X, Dong Y, Hua Y, Zhang H, Gao J, Zhao L, Li Y, Zheng A, et al. 2017. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes. Int J Nanomedicine. 12:5487–5500. doi: 10.2147/IJN.S133816.
   PubMed Web of Science ®Google Scholar
• Chen-Yu G, Chun-Fen Y, Qi-Lu L, Qi T, Yan-Wei X, Wei-na L, Guang-Xi Z. 2012. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm. 430(1-2):292–298. doi: 10.1016/j.ijpharm.2012.03.042.
   PubMed Web of Science ®Google Scholar
• Cui G-J, Xu L-M, Zhou Y, Zhang J-J, Wang J-X, Chen J-F. 2013. Microfluidic fabrication of silybin nanodispersion with high dissolution rate and tunable sizes. Chem Eng J. 222:512–519. doi: 10.1016/j.cej.2013.02.101.
   Web of Science ®Google Scholar
• Ghosh I, Bose S, Vippagunta R, Harmon F. 2011. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm. 409(1-2):260–268. doi: 10.1016/j.ijpharm.2011.02.051.
   PubMed Web of Science ®Google Scholar
• Haimhoffer Á, Rusznyák Á, Réti-Nagy K, Vasvári G, Váradi J, Vecsernyés M, Bácskay I, Fehér P, Ujhelyi Z, Fenyvesi F, et al. 2019. Cyclodextrins in drug delivery systems and their effects on biological barriers. Sci Pharm. 87(4):33. doi: 10.3390/scipharm87040033.
   Web of Science ®Google Scholar
• Jermain SV, Brough C, Williams RO. 2018. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery–an update. Int J Pharm. 535(1–2):379–392. doi: 10.1016/j.ijpharm.2017.10.051.
   PubMedGoogle Scholar
• Kakran M, Sahoo NG, Tan I-L, Li L. 2012. Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods. J Nanopart Res. 14(3):1–11. doi: 10.1007/s11051-012-0757-0.
   PubMed Web of Science ®Google Scholar
• Karnik R, Gu F, Basto P, Cannizzaro C, Dean L, Kyei-Manu W, Langer R, Farokhzad OC. 2008. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 8(9):2906–2912. doi: 10.1021/nl801736q.
   PubMed Web of Science ®Google Scholar
• Keck CM, Müller RH. 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization . Eur J Pharm Biopharm. 62(1):3–16. doi: 10.1016/j.ejpb.2005.05.009.
   PubMed Web of Science ®Google Scholar
• Khan S, Matas M d, Zhang J, Anwar J. 2013. Nanocrystal preparation: low-energy precipitation method revisited. Cryst Growth Des. 13(7):2766–2777. doi: 10.1021/cg4000473.
   Web of Science ®Google Scholar
• Li X-S, Wang J-X, Shen Z-G, Zhang P-Y, Chen J-F, Yun J. 2007. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. Int J Pharm. 342(1-2):26–32. doi: 10.1016/j.ijpharm.2007.04.025.
   PubMedGoogle Scholar
• Liang H, Sun C, Feng Z, Wang X, Kong L, Zhu F, Yao J, Yuan X, Liu Z, Zhang G, et al. 2022. Study on integrated pharmacokinetics of the component-based Chinese medicine of ginkgo biloba leaves based on nanocrystalline solid dispersion technology. Int J Nanomedicine. 17:4039–4057. doi: 10.2147/IJN.S379736.
   PubMed Web of Science ®Google Scholar
• Lindfors L, Skantze P, Skantze U, Westergren J, Olsson U. 2007. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. Langmuir. 23(19):9866–9874. doi: 10.1021/la700811b.
   PubMed Web of Science ®Google Scholar
• Lu M, Ozcelik A, Grigsby CL, Zhao Y, Guo F, Leong KW, Huang TJ. 2016. Microfluidic hydrodynamic focusing for synthesis of nanomaterials. Nano Today. 11(6):778–792. doi: 10.1016/j.nantod.2016.10.006.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG. 2011. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev. 63(6):427–440. doi: 10.1016/j.addr.2010.12.007.
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Wereley ST, Shaegh SAM. 2019. Fundamentals and applications of microfluidics. Boston: Artech House.
   Google Scholar
• Qiao Y, Cao Y, Yu K, Zong L, Pu X. 2020. Preparation and antitumor evaluation of quercetin nanosuspensions with synergistic efficacy and regulating immunity. Int J Pharm. 589:119830. doi: 10.1016/j.ijpharm.2020.119830.
   PubMedGoogle Scholar
• Radtke M. 2001. Pure drug nanoparticles for the formulation of poorly soluble drugs. New Drugs. 3:62–68.
   Google Scholar
• Rahimi M, Valeh-e-Sheyda P, Rashidi H. 2017. Statistical optimization of curcumin nanosuspension through liquid anti-solvent precipitation (LASP) process in a microfluidic platform: box-Behnken design approach. Korean J Chem Eng. 34(11):3017–3027. doi: 10.1007/s11814-017-0201-3.
   Web of Science ®Google Scholar
• Ren K-W, Li Y-H, Wu G, Ren J-Z, Lu H-B, Li Z-M, Han X-W. 2017. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int J Oncol. 50(4):1299–1311. doi: 10.3892/ijo.2017.3886.
   PubMed Web of Science ®Google Scholar
• Sareen S, Mathew G, Joseph L. 2012. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig. 2(1):12–17. doi: 10.4103/2230-973X.96921.
   PubMedGoogle Scholar
• Sherikar A, Siddique MUM, More M, Goyal SN, Milivojevic M, Alkahtani S, Alarifi S, Hasnain MS, Nayak AK. 2021. Preparation and evaluation of silymarin-loaded solid eutectic for enhanced anti-inflammatory, hepatoprotective effect: in vitro-in vivo prospect. Oxid Med Cell Longev. 2021:1818513–1818538. doi: 10.1155/2021/1818538.
   Google Scholar
• Shrimal P, Jadeja G, Naik J, Patel S. 2020. A review on novel methodologies for drug nanoparticle preparation: microfluidic approach . Chem Eng Res Des. 153:728–756. doi: 10.1016/j.cherd.2019.11.031.
   Web of Science ®Google Scholar
• Shrimal P, Jadeja G, Naik J, Patel SR. 2019. Continuous microchannel precipitation to enhance the solubility of telmisartan with poloxamer 407 using Box-Behnken design approach. J Drug Deliv Sci Technol. 53(C):101225–101225.
   Google Scholar
• Takiyama H. 2012. Supersaturation operation for quality control of crystalline particles in solution crystallization. Adv Powder Technol. 23(3):273–278. doi: 10.1016/j.apt.2012.04.009.
   Web of Science ®Google Scholar
• Valencia PM, Basto PA, Zhang L, Rhee M, Langer R, Farokhzad OC, Karnik R. 2010. Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano. 4(3):1671–1679. doi: 10.1021/nn901433u.
   PubMed Web of Science ®Google Scholar
• Viçosa A, Letourneau J-J, Espitalier F, Inês Ré M. 2012. An innovative antisolvent precipitation process as a promising technique to prepare ultrafine rifampicin particles. J Cryst Growth. 342(1):80–87. doi: 10.1016/j.jcrysgro.2011.09.012.
   Web of Science ®Google Scholar
• Wang J-X, Zhang Q-X, Zhou Y, Shao L, Chen J-F. 2010. Microfluidic synthesis of amorphous cefuroxime axetil nanoparticles with size-dependent and enhanced dissolution rate. Chem Eng J. 162(2):844–851. doi: 10.1016/j.cej.2010.06.022.
   Web of Science ®Google Scholar
• Weigl BH, Bardell RL, Cabrera CR. 2003. Lab-on-a-chip for drug development. Adv Drug Deliv Rev. 55(3):349–377. doi: 10.1016/s0169-409x(02)00223-5.
   PubMed Web of Science ®Google Scholar
• Winterton JD, Myers DR, Lippmann JM, Pisano AP, Doyle FM. 2008. A novel continuous microfluidic reactor design for the controlled production of high-quality semiconductor nanocrystals. J Nanopart Res. 10(6):893–905. doi: 10.1007/s11051-007-9345-0.
   Web of Science ®Google Scholar
• Xie YJ, Lan L, Wang JX, et al. 2012. Preparation of ultrafine powder of artemisinin by antisolvent recrystallization. J Chem Eng. 63(5):1607–1614.
   Google Scholar
• Yang T, Yi FP, Zhi WZ, et al. 2021. Advances in nanocrystalline drug preparation techniques. J Pharm Sci. 56(7):1902–1910.
   Google Scholar
• Yuan Z, Liu J, Yang YN, He Y. 2021. Research and application prospect of nano-preparations prepared by microfluidic technology. Chin J Pharm. 52(04):440–450.
   Google Scholar
• Zhang H-X, Wang J-X, Shao L, Chen J-F. 2010. Microfluidic fabrication of monodispersed pharmaceutical colloidal spheres of atorvastatin calcium with tunable sizes. Ind Eng Chem Res. 49(9):4156–4161. doi: 10.1021/ie901365w.
   Web of Science ®Google Scholar
• Zhang H-X, Wang J-X, Zhang Z-B, Le Y, Shen Z-G, Chen J-F. 2009. Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm. 374(1-2):106–113. doi: 10.1016/j.ijpharm.2009.02.015.
   PubMedGoogle Scholar
• Zhao H, Wang J-X, Wang Q-A, Chen J-F, Yun J. 2007. Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor. Ind Eng Chem Res. 46(24):8229–8235. doi: 10.1021/ie070498e.
   Web of Science ®Google Scholar
• Zhu W-Z, Wang J-X, Shao L, Zhang H-x, Zhang Q-x, Chen J-F. 2010. Liquid antisolvent preparation of amorphous cefuroxime axetil nanoparticles in a tube-in-tube microchannel reactor. Int J Pharm. 395(1-2):260–265. doi: 10.1016/j.ijpharm.2010.05.018.
   PubMedGoogle Scholar